Interventional Radiology: Transjugular Intrahepatic Portosystemic Shunt

  • Shozo Hirota


TIPS (transjugular intrahepatic portosystemic shunt) is a percutaneous procedure for forming a new intrahepatic shunt in which the hepatic vein connects to the portal vein. Portal venous blood flows out through this shunt resulting in a decrease in the portal pressure. TIPS was first reported by Dr. Rosch in 1969 and clinically applied with metallic stent in 1989. Since then TIPS has been widely performed in the USA and Europe. Indications for TIPS include refractory esophageal varices, refractory ascites, and portal hypertensive gastropathy. From the laboratory data, less than 18 of MELD score are recommended for indication. In Japan, TIPS is not approved by the Ministry of Health, Labour and Welfare, so it has not been performed widely.


Portal decompression Esophageal varices Refractory ascites Portal hypertensive gastropathy 


  1. 1.
    Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiological portosystemic shunt: an experimental study. Radiology. 1969;92:1112–4.CrossRefGoogle Scholar
  2. 2.
    Colapinto RF, Stronell RD, Birch SJ, Langer B, Blendis LM, Greig PD, Gilas T. Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J. 1982;126(3):267–8.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Richter GM, Roeren T, Brado M, Nöldge G, Kauffmann GW. Long-term results after TIPSS with the Palmaz stent. Radiologe. 1994;34(4):178–82.PubMedGoogle Scholar
  4. 4.
    Yamada R, Koda Y, Hamuro M, Hayashi S, Nakamura K, Tanihata H, et al. Transjugulara intrahepatic portosystemic shunt: a new therapy for portal hypertension. Nihon Geka Gakkai Zasshi. 1996;97(1):83–8.PubMedGoogle Scholar
  5. 5.
    Nakamura K, et al. A clinical experience of transjugular intrahepatic portosystemic shunt. J Jpn Soc Gastroenterol. 1994;91:171–9.Google Scholar
  6. 6.
    Gaba RC, Khiatani VL, Knuttinen MG, Omene BO, Carrillo TC, Bui JT, et al. Comprehensive review of TIPS technical complications and how to avoid them. Am J Roentgenol. 2011;196:675–85.CrossRefGoogle Scholar
  7. 7.
    Sanyal AJ, Freedman AM, Luketic VA, Purdum PP III, Shiffman ML, DeMeo J, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997;112:889–98.CrossRefGoogle Scholar
  8. 8.
    Haskal ZJ. Transjugular intrahepatic portosystemic shunts. In: Kandarpa K, Machan L, editors. Handbook of interventional radiologic procedures. 4th ed. Baltimore: Lippincott Williams & Wilkins; 2011. p. 390–7.Google Scholar
  9. 9.
    Tripathi D, Ferguson J, Barkell H, Macbeth K, Ireland H, Redhead DN, et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol. 2006;18:225–32.CrossRefGoogle Scholar
  10. 10.
    Report of current state of portal hypertension in Japan edited by Japanese Society of Portal Hypertension; 1990. JSPH.Google Scholar
  11. 11.
    Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–7.CrossRefGoogle Scholar
  12. 12.
    Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol. 2002;37:249–52.CrossRefGoogle Scholar
  13. 13.
    LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993;187:413–20.CrossRefGoogle Scholar
  14. 14.
    Boyer TD, Haskal ZJ. American Association for the study of liver diseases practice guidelines:the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol. 2005;16:615–29.CrossRefGoogle Scholar
  15. 15.
    Hirota S, Kobayashi K, Kako Y, Takaki H, Yamakado K. Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques. Hepatol Int. 2018;12:102–11. Scholar
  16. 16.
    Kim SK, Lee KA, Sauk S, Korenblat K. Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices. Korean J Radiol. 2017;18(2):345–54.CrossRefGoogle Scholar
  17. 17.
    Lee SJ, Kim SU, Kim MD, Kim YH, Kim GM, Park SI, Won JY, Lee DY, Lee KH. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis. J Gastroenterol Hepatol. 2017;32:1487–94. Scholar
  18. 18.
    Wang YB, Zhang JY, Gong JP, Zhang F, Zhao Y. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: a meta-analysis. J Gastroenterol Hepatol. 2016;31(4):727–33.CrossRefGoogle Scholar
  19. 19.
    Saad WE, Kitanosono T, Koizumi J, Hirota S. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech Vasc Interv Radiol. 2013;16(2):101–51.CrossRefGoogle Scholar
  20. 20.
    Kumamoto M, Toyonaga A, Inoue H, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroeterol Hepatol. 2010;25(6):1129–35.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Shozo Hirota
    • 1
  1. 1.IVR CenterKonan HospitalKobeJapan

Personalised recommendations